Microparticles that block the body’s immune response to damaged tissue could help prevent further harm.
Mike OrcuttFollow @twitterapi
I’m MIT Technology Review’s research editor. I spend my days taking things extremely seriously and attempting with all my nerdy might to piece together bigger pictures from the bits and shreds of truth I manage to filter from the information barrage. I’m particularly obsessed with the energy-related challenges facing humanity and the future of the Internet.
Mike Orcutt's Stories
The ability to print retinal cells could lead to new therapies for retinal disorders such as macular degeneration.
A novel vaccine design could lead to new weapons against often deadly bacterial infections.
Coal could be a source of cheap, nontoxic fluorescent nanoparticles useful for biomedicine.
New inks and tools allow 3-D printing of lithium-ion technology.
Kateeva says its new manufacturing equipment can produce affordable displays based on organic light-emitting diodes.
The history of electric cars is long and full of false starts. But it looks as if the latest wave won’t be turned back.
There appears to be more than enough room to bury our emissions, but large-scale carbon capture remains untested.
A layer-by-layer fabrication tool lets researchers quickly form complicated biological tissue in three-dimensional space.
Researchers are designing a “dialysis-like” machine that could identify and remove pathogens responsible for an often lethal blood infection.